234 related articles for article (PubMed ID: 25762713)
1. Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials.
Kim SY; Karlawish J; Berkman BE
Neurology; 2015 Apr; 84(14):1488-94. PubMed ID: 25762713
[TBL] [Abstract][Full Text] [Related]
2. Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials.
Grill JD; Zhou Y; Elashoff D; Karlawish J
Neurobiol Aging; 2016 Mar; 39():147-53. PubMed ID: 26923411
[TBL] [Abstract][Full Text] [Related]
3. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
[TBL] [Abstract][Full Text] [Related]
4. Ethics and Bias in Clinical Trial Enrollment in Stroke.
Majersik JJ
Curr Cardiol Rep; 2019 Apr; 21(6):49. PubMed ID: 31011843
[TBL] [Abstract][Full Text] [Related]
5. Improving subject recruitment by maintaining truly informed consent: a practical benefit of disclosing adverse clinical trial results.
Shah KR; Batzer FR
Am J Bioeth; 2009 Aug; 9(8):36-7. PubMed ID: 19998157
[No Abstract] [Full Text] [Related]
6. Ethical Issues in the Development of Readiness Cohorts in Alzheimer's Disease Research.
Milne R; Bunnik E; Tromp K; Bemelmans S; Badger S; Gove D; Maman M; Schermer M; Truyen L; Brayne C; Richard E
J Prev Alzheimers Dis; 2017; 4(2):125-131. PubMed ID: 29186282
[TBL] [Abstract][Full Text] [Related]
7. Ethical and scientific considerations for patient enrollment into concurrent clinical trials.
Myles PS; Williamson E; Oakley J; Forbes A
Trials; 2014 Nov; 15():470. PubMed ID: 25433679
[TBL] [Abstract][Full Text] [Related]
8. What do people at risk for Alzheimer disease think about surrogate consent for research?
Kim SY; Kim HM; McCallum C; Tariot PN
Neurology; 2005 Nov; 65(9):1395-401. PubMed ID: 16275826
[TBL] [Abstract][Full Text] [Related]
9. Ethical Frameworks for Disclosure of Alzheimer Disease Biomarkers to Research Participants: Conflicting Norms and a Nuanced Policy.
Bunnik EM; Smedinga M; Milne R; Georges J; Richard E; Schermer MHN
Ethics Hum Res; 2022 Nov; 44(6):2-13. PubMed ID: 36316970
[TBL] [Abstract][Full Text] [Related]
10. What do people at risk for Alzheimer disease think about surrogate consent for research?
Schenk DB; Gilman S
Neurology; 2006 Jun; 66(11):1785-6. PubMed ID: 16769971
[No Abstract] [Full Text] [Related]
11. Non-completion and informed consent.
Wertheimer A
J Med Ethics; 2014 Feb; 40(2):127-30. PubMed ID: 23371314
[TBL] [Abstract][Full Text] [Related]
12. Exception from informed consent: viewpoint of institutional review boards--balancing risks to subjects, community consultation, and future directions.
Ernst AA; Fish S
Acad Emerg Med; 2005 Nov; 12(11):1050-5. PubMed ID: 16264073
[TBL] [Abstract][Full Text] [Related]
13. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials.
Vanderpool HY
Xenotransplantation; 2009; 16(4):255-62. PubMed ID: 19799766
[TBL] [Abstract][Full Text] [Related]
14. Ethical issues in non-intervention trials for thyroid cancer.
Angelos P; Hartl DM; Shah JP; Nixon IJ; Owen RP; Rinaldo A; Rodrigo JP; Shaha AR; Silver CE; Suárez C; Ferlito A
Eur J Surg Oncol; 2018 Mar; 44(3):316-320. PubMed ID: 28343732
[TBL] [Abstract][Full Text] [Related]
15. Money and distorted ethical judgments about research: ethical assessment of the TeGenero TGN1412 trial.
Emanuel EJ; Miller FG
Am J Bioeth; 2007 Feb; 7(2):76-81. PubMed ID: 17366206
[TBL] [Abstract][Full Text] [Related]
16. Informed recruitment in partner studies of HIV transmission: an ethical issue in couples research.
McNutt LA; Gordon EJ; Uusküla A
BMC Med Ethics; 2009 Aug; 10():14. PubMed ID: 19709442
[TBL] [Abstract][Full Text] [Related]
17. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
18. Lay public's understanding of equipoise and randomisation in randomised controlled trials.
Robinson EJ; Kerr CE; Stevens AJ; Lilford RJ; Braunholtz DA; Edwards SJ; Beck SR; Rowley MG
Health Technol Assess; 2005 Mar; 9(8):1-192, iii-iv. PubMed ID: 15763039
[TBL] [Abstract][Full Text] [Related]
19. Informed consent for Alzheimer's disease clinical trials: a survey of clinical investigators.
Karlawish JH; Knopman D; Clark CM; Morris JC; Marson D; Whitehouse PJ; Kawas CH
IRB; 2002; 24(5):1-5. PubMed ID: 12737167
[No Abstract] [Full Text] [Related]
20. Is there an ethical obligation to disclose controversial risk? A question from the ACCORD Trial.
DeMarco JP; Ford PJ; Patton DJ; Stewart DO
Am J Bioeth; 2014; 14(4):4-10. PubMed ID: 24730479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
